In a 68-year-old woman with hypertension at high risk for cardiovascular disease, is the combination of Telmisartan and Ramipril more effective in controlling hypertension and reducing cardiovascular risk than either drug alone?
No direct evidence for the combination of Telmisartan and Ramipril over monotherapy in controlling hypertension and reducing cardiovascular risk was found; combination therapy does not show additional cardiovascular benefits and may increase renal risk.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24376242
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00